AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05375552 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Transcranial direct current stimulation
Description: Participants will experience two repeated 20 minute sessions of tDCS (1.2 mA), with a 10-minute break.
Study NCT04927234 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: geko™ therapy
Description: Neuro-muscular electrical stimulation of the peroneal nerve
Study NCT04730583 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Kybella
Description: Injection into the cutaneous Neurofibromas lesion
Study NCT04730583 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 1064nm laser
Description: Pulse laser at a wavelength of 1064nm to the cutaneous Neurofibromas lesion
Study NCT04730583 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 755nm Alexandrite Laser
Description: Pulse laser at a wavelength of 755nm to the cutaneous Neurofibromas lesion
Study NCT05739851 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DA-1229_01 2.5/500mg (Before)
Description: single dose administration (one tablet once a day)
Study NCT05739851 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DA-1229_01 2.5/500mg (After)
Description: single dose administration (one tablet once a day)
Study NCT06386614 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Routine treatment
Description: Both groups were given routine treatment
Study NCT06386614 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Routine treatment
Description: Both groups were given routine treatment
Study NCT06386614 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Transcranial Direct Current Stimulation
Description: The common group routine training used sham TDCS stimulation, and the experimental group used real TDCS stimulation
Study NCT05563753 — intervention group
Intervention type: DRUG
Intervention: ABT
Description: any antibiotic therapy in the first week of life
Study NCT05413252 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Practice Facilitation
Description: Practices will be assigned a practice facilitator who will support practices in implementing all practice redesign components associated with TBC for HTN management.
Study NCT04974294 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: PPV23
Description: random allocation 1:1:1 IM injection
Study NCT04974294 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: PCV13
Description: random allocation 1:1:1 IM injection
Study NCT04974294 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Saline for injection
Description: random allocation 1:1:1 IM injection
Study NCT06304142 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Rehabilitation therapy
Description: Rehabilitation therapy includes Diet management: Avoiding consumption of irritant foods and beverages, such as spicy foods, caffeine, alcohol, and acidic foods. Controlling portion sizes and meal timing, and adopting smaller, more frequent meals.~Lifestyle adjustments: Avoiding lying down or bending immediately after meals, maintaining a sitting or upright position for at least 2 hours. Adjusting sleeping positions by elevating the head of the bed to reduce nighttime acid reflux. Avoiding excessive exertion and managing stress levels.~Rehabilitation training: Strengthening the control of esophageal and gastric muscles through rehabilitation exercises to improve the function of the gastroesophageal sphincter and prevent gastric fluid reflux.
Study NCT06304142 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Rehabilitation therapy
Description: Rehabilitation therapy includes Diet management: Avoiding consumption of irritant foods and beverages, such as spicy foods, caffeine, alcohol, and acidic foods. Controlling portion sizes and meal timing, and adopting smaller, more frequent meals.~Lifestyle adjustments: Avoiding lying down or bending immediately after meals, maintaining a sitting or upright position for at least 2 hours. Adjusting sleeping positions by elevating the head of the bed to reduce nighttime acid reflux. Avoiding excessive exertion and managing stress levels.~Rehabilitation training: Strengthening the control of esophageal and gastric muscles through rehabilitation exercises to improve the function of the gastroesophageal sphincter and prevent gastric fluid reflux.
Study NCT06304142 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Injection
Description: The percutaneous approach via the paratracheal route was used for Stellate ganglion block. The operator stood on the side of the block, instructed the patient to lie supine with a thin pillow placed below the shoulders, and tilted the head 45° towards the blocked side, fully exposing the neck. Then, routine disinfection of the neck skin was performed. The puncture site was located 2.5 cm above the sternoclavicular joint and 1.5 cm lateral to the midline of the neck.
Study NCT06304142 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Injection
Description: The percutaneous approach via the paratracheal route was used for Stellate ganglion block. The operator stood on the side of the block, instructed the patient to lie supine with a thin pillow placed below the shoulders, and tilted the head 45° towards the blocked side, fully exposing the neck. Then, routine disinfection of the neck skin was performed. The puncture site was located 2.5 cm above the sternoclavicular joint and 1.5 cm lateral to the midline of the neck.
Study NCT06304142 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine hydrochloride
Description: Based on the invention above, the patients in the observation group were provided with Stellate ganglion block, using 1.5ml of 2% Lidocaine hydrochloride (1ml: 0.5mg) and 500ug of Vitamin B12 (1ml: 0.5g).
Study NCT06312878 — intervention group
Intervention type: OTHER
Intervention: Describe the anatomy of the IVC in the case of an anatomical variant
Description: Evaluated technique by collecting data from the medical record.
Study NCT06582134 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Sham BMBI
Description: Participants are requested to listen to the recordings 3 times a week, for 3 months (in a standardized sequence e.g., 1-2-3 and repeat) on Mondays-Wednesdays-Fridays. They are instructed to listen right before they sleep and encouraged to use them whenever they feel stressed or in pain.
Study NCT06197594 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Proprioceptive neuromuscular facilitation techniques
Description: Proprioceptive neuromuscular facilitation techniques
Study NCT06197594 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Rebound Therapy
Description: Rebound Therapy
Study NCT05150535 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Hypofractionation Radiotherapy.
Description: Patients will receive 40 Gy in 15 fractions to the entire breast and or chest wall over the course of 3 weeks.
Study NCT05150535 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Ultra-hypofractionation radiotherapy
Description: Patients will receive 26 Gy in 5 fractions to the entire breast and or chest wall over the course of one week.
Study NCT05509166 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: LGBTQ-affirmative Cognitive Behavioral Therapy
Description: 10-session LGBTQ-affirmative psychotherapy using CBT techniques
Study NCT05509166 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: LGBTQ-affirmative Treatment-As-Usual
Description: 10-session LGBTQ-affirmative psychotherapy
Study NCT05979974 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: High energy density pulse electromagnetic field
Description: The treatment coil is placed over the shoulder region at the maximum pain point for 9 minutes. A high energy of high-PEMF with a rate of 3 pulse per second is applied to the patient.
Study NCT05979974 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: physiotherapy
Description: Physiotherapy such as shoulder passive and active-assisted range of motion (ROM) exercises, Pendulum exercises, Codman's exercises and Cross-body reach exercises. Under the physiotherapist's guidance, the patient receives the training session about 30 minutes every time.
Study NCT05979974 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: physiotherapy
Description: Physiotherapy such as shoulder passive and active-assisted range of motion (ROM) exercises, Pendulum exercises, Codman's exercises and Cross-body reach exercises. Under the physiotherapist's guidance, the patient receives the training session about 30 minutes every time.
Study NCT05979974 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham High energy density pulse electromagnetic field
Description: The sham treatment coil is placed over the shoulder region at the maximum pain point for 9 minutes. The setting is the same as the experimental group(high energy, a rate of 3 pulse per second) with the difference that the energy output doesn't export to the patient.
Study NCT06289192 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: C-Raven Virtual Tobacco Cessation Counseling
Description: A two-module tobacco cessation intervention that involves interaction with a virtual counselor and includes instruction about addiction and the use of pharmacotherapy for cessation. Each module takes approximately 20 minutes to complete.
Study NCT06289192 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Product
Description: Participants will be offered a 12-week supply of nicotine patches and either nicotine gum or lozenges.
Study NCT06582134 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BMBI
Description: Participants are requested to listen to the recordings 3 times a week, for 3 months (in a standardized sequence e.g. A-B-C and repeat) on Mondays-Wednesdays-Fridays. They are instructed to listen right before they sleep and encouraged to use them whenever they feel stressed or in pain.
Study NCT05984888 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MIND Diet Intervention Group
Description: Participants will receive individually tailored nutrition counseling on adopting the MIND diet pattern from a registered dietitian nutritionist (RDN) for a total of 8 sessions spanning 12 weeks. After completing the counseling sessions participants will be followed up 6 months later to collect additional questionnaires and assessments.
Study NCT05984888 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: General Health Curriculum (GHC) Group
Description: Participants will meet with trained study staff for 8 sessions spanning 12 weeks covering content on non-diet related health topics. After these sessions, participants will be followed up 6 months later to collect additional questionnaires and assessments. Once 6-month follow-up has been completed, participants will be offered to receive the MIND diet intervention offered in the MIND Diet Intervention Group.
Study NCT04707261 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Description: Participants will receive dapagliflozin 10 mg once daily
Study NCT04707261 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will receive placebo 10 mg once daily
Study NCT06289192 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Community Health Worker
Description: A community health worker will meet with each participant throughout the study period to teach appropriate NRT usage, discuss barriers/facilitators to NRT use and cessation, conduct shared decision-making about lung cancer screening, and provide health system navigation when needed.
Study NCT06289192 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lung Cancer Screening
Description: Eligible participants will be referred to their primary care physician or existing specialist to complete lung cancer screening.
Study NCT06414967 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music Intervention
Description: Music therapy carried out with Music Care
Study NCT06436846 — intervention group
Intervention type: OTHER
Intervention: Biospecimen sample collection during standard-of-care surgery
Description: Patients in this observational study are undergoing planned surgical resection of their retroperitoneal sarcoma as prescribed by their primary surgeon and treatment team. In addition to removal of the primary tumor, surgeons remove 4 samples of retroperitoneal fat and a sample of subcutaneous fat for further study at the time of the operation.
Study NCT06484998 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dental anxiety level and child's compomer colors selection
Description: Patients without any syndromes or systemic disorders, without mental retardation, who needed restorative treatment for primary molars were included in the study. The examination forms of 275 patients requiring restorative treatment of primary teeth were analysed at the session they came for restorative treatment. To determine the child's anxiety, the Modified Child Dental Anxiety Scale-faces version was administered to the children before restorative treatment. The children were asked to choose from a scale consisting of 9 colours (pink, blue, gold, silver, orange, yellow, green, purple, white) for the compomer restoration color selections. The patients were asked what their favourite color was after the compomer restoration color selection so that the previous question would not have any effect on the child's restoration color selection.
Study NCT05350033 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: tDCS - tDCS
Description: active-tDCS administered during 10 sessions, in Phase 1 and Phase 2
Study NCT05350033 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: tDCS - Sham
Description: active-tDCS administered during 5 sessions, in Phase 1
Study NCT05346653 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: SGLT2i
Description: dapagliflozin (10 mg daily)
Study NCT05346653 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: No SGLT2i
Description: No SGLT2i
Study NCT06551259 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: Intravenous infusion of 0.6μg/kg load dose of dexmedetomidine within 10 minutes after intubation, followed by continuous infusion at a rate of 0.4 μg/kg/h until 30 minutes before the end of surgery
Study NCT06551259 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: physiological saline
Description: physiological saline
Study NCT05763771 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Smart Phone App
Description: Collection of data
Study NCT05763771 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: NIcotine Patches
Description: Place on the skin
Study NCT05013125 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: ENDO-AID CADe assisted Colonoscopy
Description: ENDO-AID is a dedicated endoscopy Computer-Aided Diagnosis (CADe) system where suspicious lesions are automatically detected and highlighted on the main monitor in real-time, alerting the endoscopist during the procedure.
Study NCT05350033 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham - tDCS
Description: active-tDCS administered during 5 sessions, in Phase 2
Study NCT05350033 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham - Sham
Description: sham-tDCS administered during 10 sessions, in Phase 1 and Phase 2
Study NCT04768426 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: 1000 mg/m2 administered on Days 1 to 14 of 21-day treatment cycles, for 8 cycles.
Study NCT06427850 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Description: receive an injection of Tranexamic acid into the surgical site
Study NCT06427850 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: receive an injection of Normal saline into the surgical site
Study NCT05257681 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Interlobar fissure completion and pleural adhesiolysis
Description: A video-assisted thoracic surgery or robotic approach will be used to perform pleural adhesiolysis and the lobar fissure adjacent to the previously targeted lobe during bronchoscopic lung volume reduction will be completed using a surgical stapler.
Study NCT06158919 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fruquintinib、Nivolumab、Sintilimab、Oxaliplatin、Teysuno、Capecitabine
Description: Combined treatment period: A total of 6 cycles of combined treatment Fruquintinib: 4 mg/d, qd po, d1-14, q3w. Nivolumab: 360mg iv.gtt d1, q3w or Sintilimab: 200mg iv.gtt d1, q3w SOX : Oxaliplatin 130mg/m2 iv.gtt d1, Teysuno 40mg/m2 p.o.b.i.d. d1\~ 14q3w. Or XELOX regimen: oxaliplatin 130mg/m2 iv.gtt d1 Capecitabine 1000mg/m2 p.o. b.i.d. d1\~ 14q3w.~Maintenance treatment period:~Fruquintinib: 4 mg/d, qd po, d1-14, q3w. Nivolumab: 360mg iv.gtt d1, q3w or Sintilimab: 200mg iv.gtt d1, q3w Teysuno 40mg/m2 p.o.b.i.d. d1\~14 q3w or Capecitabine 1000mg/m2 p.o.b.i.d. d1\~14 q3w.~Maintenance of treatment until disease progression or toxicity becomes intolerable.
Study NCT04718454 — intervention group
Intervention type: DEVICE
Intervention: dental attachment
Description: This research aimed to evaluate the retentive power and wear of the smart box attachment use with tilted two implant assisted mandibular overdenture
Study NCT06582329 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alfa1 Antitrypsin
Description: Participants will be treated intravenously with A1AT 120 mg/kg bodyweight once a week for 4 weeks (4 total infusions).
Study NCT06583486 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Rcombinant botulinum neurotoxin type A for injection (YY001)
Description: Five sites will be injected at 0.05 mL each, 2 sites in corrugator muscle of each side and 1 site in the procerus muscle, for a total dose of 20U.
Study NCT06297421 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Fecal Microbiota Transplantation
Description: Oral Fecal Microbiota Transplantation Capsule
Study NCT06297421 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral Placebo Capsule
Study NCT05488093 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: X-sens sensor
Description: the procedure will include:~* 7 to 8 sensors (Foot, leg, thigh, pelvis and chest possibly).~* 5 movements/exercises for the patients, each exercise performed 3 times except walking~* Analysis of 20m walking cycle (normal speed, most natural arm movement, 4 return trips of 20m):~* Climbing up and down stairs (using the public stairs of the rheumatology access department, 6 steps of 20 cm height, at normal speed, without using the handrail)~* Getting up from a chair without the help of hands (start standing, then the patient sits, leans and stands up, feet together, without taking the feet off the floor, using one and the same chair for each patient with a height of 50 cm)
Study NCT05462418 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: electrosurgery
Description: incisions completed using use the unipolar diathermy from Whiteline till we reach the parietal peritoneum (cutting the Whiteline then coagulation till reaching the peritoneum). The used diathermy frequency was 50-70 MHz.
Study NCT05462418 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: scalpel
Description: patients had their incisions completed using the surgical scalpel till we reach the parietal peritoneum.
Study NCT05039710 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-75220795
Description: JNJ-75220795 will be administered as SC injection.
Study NCT05039710 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching placebo will be administered as SC injection.
Study NCT05869864 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Schools Championing Safe South Africa
Description: The intervention consists of 2 parts - a poster campaign with social norms messages on violence and HIV risk, and 2 lessons in life orientation (a health curriculum delivered during school).
Study NCT04736628 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Avenciguat
Description: Avenciguat
Study NCT04736628 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT06549660 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active PBMT
Description: Active with a dose of 165 J per site, resulting in a total dose of 495J.
Study NCT06549660 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo PBMT
Description: Placebo, without therapeutic dose.
Study NCT06303219 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: RADITIONAL MODERATE INTENSITY TRAINING
Description: It consists of patients who will receive High-intensity interval training, including running as well as walking at 80% to 95% HR peak. Which is monitored by a smart watch. Before starting treatment, it follows a 10-minute warm-up exercise which includes basic stretches (Quads, Hams, and calf muscles) with a 30-second hold of both legs and same exercise will be pursued for the cool-down period. This intervention will be performed 5 days per week for 4 weeks.~The total duration of this session will be 50 minutes
Study NCT06303219 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: HIGH INTENSITY INTERVAL TRAINING
Description: It consists of patients who will receive Moderate-intensity interval training, including running as well as walking at 60% HR peak. Which is monitored by a smart watch. Before starting treatment, it follows a 10-minute warm-up exercise which includes basic stretches (Quads, Hams, and calf muscles) with a 30-second hold of both legs and same exercise will be pursued for the cool-down period. This intervention will be performed 5 days per week for 4 weeks.~The total duration of this session will be 50 minutes (